Sonographic Gallbladder Abnormality Is Associated with Intravenous Immunoglobulin Resistance in Kawasaki Disease

Sonographic Gallbladder Abnormality Is Associated with Intravenous Immunoglobulin Resistance in Kawasaki Disease

Objective. Kawasaki disease (KD) is an acute systematic vasculitis in children which causes coronary arterial lesions and hydrops of gallbladder. Our objective is to correlate the clinical significance and influence on disease outcome of patients with gallbladder abnormalities in Kawasaki dissease....

Full description

Saved in:

Bibliographic Details
Main Authors:	Chih-Jen Chen, Fu-Chen Huang, Mao-Meng Tiao, Ying-Hsien Huang, Li-Yan Lin, Hong-Ren Yu, Kuender D. Yang, Yi-Chuan Huang, Chih-Cheng Chen, Wei-Chiao Chang, Ho-Chang Kuo
Format:	Article
Language:	English
Published:	Wiley 2012-01-01
Series:	The Scientific World Journal
Online Access:	http://dx.doi.org/10.1100/2012/485758
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

FCGR2A Promoter Methylation and Risks for Intravenous Immunoglobulin Treatment Responses in Kawasaki Disease
by: Ho-Chang Kuo, et al.
Published: (2015-01-01)

Timing of Intravenous Immunoglobulin Treatment and Risk of Coronary Artery Abnormalities in Children with Kawasaki Disease
by: Aswine K. Bal, et al.
Published: (2014-10-01)

Optimizing the speed of intravenous immunoglobulin infusion for Kawasaki Disease
by: Chia-Yi Chin, MD, MS
Published: (2024-09-01)

A machine learning-based model to predict intravenous immunoglobulin resistance in Kawasaki disease
by: Yuhan Xia, et al.
Published: (2025-03-01)

Interpretable web-based machine learning model for predicting intravenous immunoglobulin resistance in Kawasaki disease
by: Ying He, et al.
Published: (2025-06-01)

Clinical prediction of intravenous immunoglobulin-resistant Kawasaki disease based on interpretable Transformer model
by: Gahao Chen, et al.
Published: (2025-01-01)

Clinical prediction of intravenous immunoglobulin-resistant Kawasaki disease based on interpretable Transformer model.
by: Gahao Chen, et al.
Published: (2025-01-01)

EXPERIENCE OF INTRAVENOUS INJECTION OF NORMAL HUMAN IMMUNOGLOBULIN IN A PATIENT WITH KAWASAKI SYNDROME
by: T. V. Sleptsova, et al.
Published: (2014-07-01)

DC-SIGN (CD209) Promoter −336 A/G (rs4804803) Polymorphism Associated with Susceptibility of Kawasaki Disease
by: Hong-Ren Yu, et al.
Published: (2012-01-01)

A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?
by: Wei Li, et al.
Published: (2021-01-01)

Effect of additional intravenous immunoglobulin for infliximab-refractory Kawasaki disease: a cohort study
by: Satoki Hatano, et al.
Published: (2025-05-01)

The efficacy and safety of intravenous immunoglobulin infusion in 12 h for the initial treatment of Kawasaki disease
by: Satoshi Asano, et al.
Published: (2024-09-01)

Novel Predictive Scoring System for Intravenous Immunoglobulin Resistance Helps Timely Intervention in Kawasaki Disease: The Chinese Experience
by: Yan Wang, et al.
Published: (2023-01-01)

Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease
by: Serkan Türkuçar, et al.
Published: (2020-02-01)

A visualized nomogram to predict intravenous immunoglobulin resistance in Kawasaki disease: a study based on the population in Southern China
by: Xinping Lin, et al.
Published: (2025-04-01)

Population-Based Study of the Association between Urbanization and Kawasaki Disease in Taiwan
by: Wei-Pin Chang, et al.
Published: (2013-01-01)

Sonographic diagnosis of intramural duodenal hematoma
by: Chih-Hao Wang, et al.
Published: (2023-01-01)

Association of Kawasaki disease with intellectual disability, attention deficit hyperactivity disorder, and autism spectrum disorder: a systematic review and meta-analysis
by: Chih-Wei Hsu, et al.
Published: (2025-02-01)

High Efficiency of Human Normal Immunoglobulin for Intravenous Administration in a Patient with Kawasaki Syndrome Diagnosed in the Later Stages
by: Tatyana V. Sleptsova, et al.
Published: (2016-09-01)

The effects of glucocorticoid plus intravenous immunoglobulin (IVIG) vs IVIG alone on platelet activation in children with Kawasaki disease
by: Qiong-Qiong Wang, et al.
Published: (2023-08-01)

Impact of intravenous immunoglobulin treatment on peripheral blood cells in children with Kawasaki disease complicated with coronary artery lesion
by: Junshan Zhao, et al.
Published: (2025-02-01)

THE SONOGRAPHIC DYNAMICS OF PERIPHERAL NERVES CROSS SECTIONAL AREA CHANGES IN MULTIFOCAL MOTOR NEUROPATHY TREATED WITH INTRAVENOUS IMMUNOGLOBULIN: CASE REPORT
by: S. S. Nikitin, et al.
Published: (2017-01-01)

Establishment and validation of risk prediction model to predict intravenous immunoglobulin-resistance in Kawasaki disease based on meta-analysis of 15 cohorts
by: Shuhui Wang, et al.
Published: (2025-02-01)

Association between C-reactive protein–albumin–lymphocyte (CALLY) index with intravenous immunoglobulin non-response in Kawasaki disease
by: Yan Duan, et al.
Published: (2025-12-01)

Sonographic diagnosis of portal venous gas in necrotizing enterocolitis
by: Po-Chih Lin, et al.
Published: (2022-01-01)

Sonographic assessment of hand and wrist tendons abnormalities
by: Asmaa Hussein Habib, et al.
Published: (2024-12-01)

Is there an association between intravenous immunoglobulin resistance and coronary artery lesion in Kawasaki disease?-Current evidence based on a meta-analysis.
by: Xiaolan Zheng, et al.
Published: (2021-01-01)

The predictive value of urinary albumin-to-creatinine ratio for coronary artery abnormalities in Kawasaki disease
by: Ye Chen, et al.
Published: (2025-06-01)

Eggerthella lenta down regulated flavone and flavonol biosynthesis promoted Kawasaki disease
by: Yao-Tsung Yeh, et al.
Published: (2025-12-01)

Treatment of a patient with Kawasaki disease associated with selective IgA deficiency by continuous infusion of cyclosporine A without intravenous immunoglobulin
by: Tatsuya Anzai, et al.
Published: (2016-12-01)

Clinical Manifestations Vary with Different Age Spectrums in Infants with Kawasaki Disease
by: Hao-Chuan Liu, et al.
Published: (2012-01-01)

Efficacy of intravenous immunoglobulin in recurrent pregnancy loss: a retrospective analysis of patients with abnormal cellular immunity
by: Jae Won Han, et al.
Published: (2025-06-01)

INTRAVENOUS IMMUNOGLOBULIN IN PEDIATRIC RHEUMATOLOGY PRACTICE
by: E. I. Alexeeva, et al.
Published: (2015-04-01)

The place of intravenous immunoglobulin in rheumatic diseases
by: N. V. Seredavkina, et al.
Published: (2016-01-01)

INTRAVENOUS IMMUNOGLOBULIN APPLICATION IN CLINICAL PRACTICE
by: T. V. Latysheva, et al.
Published: (2013-01-01)

Use of Intravenous Immunoglobulins in Intensive Therapy
by: E. A. Latysheva, et al.
Published: (2012-06-01)

A Comparative Study of Intravenous Immunoglobulin and Lipid Emulsion in Patients With Reproductive Failures Associated With NK Cell Abnormalities
by: Ayano Yamaya, et al.
Published: (2025-01-01)

Falsely abnormal serum protein electrophoresis after administration of intravenous immunoglobulins (IVIG): A retrospective cohort study
by: Andrew Sulaiman, et al.
Published: (2024-11-01)

Identifying the risk of Kawasaki disease based solely on routine blood test features through novel construction of machine learning models
by: Tzu-Hsien Yang, et al.
Published: (2025-01-01)

Reaction at the Bacillus Calmette–Guérin Inoculation Site in Patients with Kawasaki Disease
by: Chi-Chieh Lai, et al.
Published: (2013-02-01)